Insights from
UBC's Expert Voices

This article explores strategies to enhance Patient Service Programs (PSPs) awareness through digital engagement and provider collaboration.

Learn about the FDA's new guidance, the challenges of standardization, and how UBC is driving innovation in REMS implementation using modern APIs from UBC's VP of Data Intelligence and Program Analytics, Jim Shamp.

Discover UBC's insights from the Cell & Gene Meeting on the Mesa, the unique challenges patients face, and the importance of tailored support services to ensure successful treatment journeys

Supporting National Kidney Week 2024

UBC talked to Pharmaceutical Commerce about what artificial intelligence capabilities could do to impact patient access in 2024 and beyond.

In the realm of pharmaceuticals, regulatory compliance is paramount to ensure patient safety. With the complex environment of safety reporting, several vendors may be involved at global and local levels for performing submission activities to health authorities, ethics committees and investigators. Director of UBC Global Case Processing, Myrto Ioannidi and UBC Team Manager, Esther Aparicio review […]

Clinical trials provide a limited view of patient experience but this can be expanded through tokenization to link pre- and post-trial data.

For most pharmaceutical companies, hiring a PV team will help alleviate some of the work of the existing internal team.

Putting the patient back in patient services means we do more, go deeper, and customize offerings.